Barbara Dunn, Ph.D., M.D., is a Medical Officer in the Biometry Research Group.
Dr. Dunn collaborates on clinical and preclinical projects. She has managed contracts involving preclinical development of preventive drugs, including vaccines. She served as medical monitor on phase 2 breast cancer prevention trials. Dr. Dunn was a Medical Officer in the National Cancer Institute (NCI) Community Oncology Research Program (NCORP) overseeing large phase 3 breast cancer prevention trials. She also conducted and collaborated on genomics research in breast cancer prevention. In 2007, Dr. Dunn directed the Cancer Prevention Fellowship Program and the Summer Curriculum in Cancer Prevention. Dr. Dunn has provided mentorship and teaching to fellows and students on a variety of projects.
Prior to joining the Division of Cancer Prevention (DCP), Dr. Dunn was a senior scientist and medical oncology attending in the clinic of NCI’s Biological Response Modifier Program where she managed patients participating in translational studies involving lymphoma treatments and immunological cancer therapies. She received her Ph.D. in Genetics from the University of Wisconsin and her M.D. and Internal Medicine training from Georgetown University Medical School and Hospital. She trained in Medical Oncology at NCI. Her research interests include chemoprevention and immunoprevention, breast cancer, clinical cancer genetics and genomics, and screening and overdiagnosis.